Skip to main content
. 2022 Apr 25;11(5):573. doi: 10.3390/antibiotics11050573

Figure 3.

Figure 3

Figure 3

(A) MTT Assay to confirm the antimicrobial activity of whole AGE against C. albicans M207 at different time intervals. Cell viability of 21.8% was observed at 1.25 mg at 12 h (MIC50) and n = 3. The Assay was performed in triplicate. (B) MTT Assay to confirm the antimicrobial activity of whole AGE E. coli ATCC 39936 at different time intervals. Cell viability of 20.97% was observed at 1.25 mg at 12 h (MIC50) and n = 3. The Assay was performed in triplicate. (C) MTT Assay to confirm the antimicrobial activity of whole AGE against C. albicans M207+ E. coli ATCC 39936 at different time intervals. Cell viability of 13.06% was observed at 1.25 mg at 12 h (MIC50) and n = 3. All values are expressed as mean and standard deviation.